Shkreli Taunts Congress as Judge Lets Him Attend Hearing
- Ex-biotech CEO received subpoena to testify on drug pricing
- Shkreli faces securities case, said he will plead the Fifth
Meet Martin Shkreli, Internet Star
This article is for subscribers only.
Former biotech executive Martin Shkreli can go to Washington to testify at a congressional hearing on drug pricing, though he’s vowed to plead the Fifth even as he posted messages on Twitter taunting politicians.
Shkreli, who gained notoriety for boosting the price of a decades-old anti-parasitic treatment his company acquired to $750 a pill from $13.50, was directed to appear before the House Committee on Oversight and Government Reform. A hearing scheduled for Tuesday was postponed to Feb. 4 because of a snowstorm in Washington over the weekend.